Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kneitz

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 15, 2010
[Dithiols as chelators. A cause of bullous skin reactions]J Storim, J Stoevesandt, D Anders, et al.
The British Journal of Dermatology|May 15, 2018
Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinomaV Haug, V Behle, S Benoit, et al.
The British Journal of Dermatology|December 17, 2008
Major response to paclitaxel combined with irradiation as second-line therapy in metastatic angiosarcoma of the face and scalpU B Hofmann, M Wobser, H Kneitz, et al.
Journal of Clinical Pathology|April 7, 2007
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomyM Hofmann, O Stoss, T Gaiser, et al.
The British Journal of Dermatology|November 28, 2019
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit diseaseJ Weber, V Glutsch, E Geissinger, et al.
The British Journal of Dermatology|November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathwayK Maurus, C Kosnopfel, H Kneitz, et al.
ESMO Open|May 25, 2024
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upI Lugowska, J C Becker, P A Ascierto, et al.
Zeitschrift Fur Rheumatologie|October 8, 2011
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]J R Kalden, H Burkhardt, B Buss, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 15, 2010
[Dithiols as chelators. A cause of bullous skin reactions]J Storim, J Stoevesandt, D Anders, et al.
The British Journal of Dermatology|May 15, 2018
Pembrolizumab-associated mucous membrane pemphigoid in a patient with Merkel cell carcinomaV Haug, V Behle, S Benoit, et al.
The British Journal of Dermatology|December 17, 2008
Major response to paclitaxel combined with irradiation as second-line therapy in metastatic angiosarcoma of the face and scalpU B Hofmann, M Wobser, H Kneitz, et al.
Journal of Clinical Pathology|April 7, 2007
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomyM Hofmann, O Stoss, T Gaiser, et al.
The British Journal of Dermatology|November 28, 2019
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit diseaseJ Weber, V Glutsch, E Geissinger, et al.
The British Journal of Dermatology|November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathwayK Maurus, C Kosnopfel, H Kneitz, et al.
ESMO Open|May 25, 2024
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upI Lugowska, J C Becker, P A Ascierto, et al.
Zeitschrift Fur Rheumatologie|October 8, 2011
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]J R Kalden, H Burkhardt, B Buss, et al.
Pageof 2